Tian Quanfa, Li Jinjie, Fan Xiaolong, Yao Liling, Xia Shanshan, Wu Zhihua, Zhang Jingxiao, Ren Yaoqiang, Han Xiaofan, Wang Xiaozhen
Department of Reproduction, Fenyang Hospital, Lvliang, China.
Department of Reproduction, Shanxi Medical University Affiliated Fenyang Hospital, Lvliang, China.
Transl Androl Urol. 2025 Jul 30;14(7):1874-1881. doi: 10.21037/tau-2025-91. Epub 2025 Jul 28.
Two-suture longitudinal intussusception vasoepididymostomy (LIVE) surgery has been confirmed by many studies in the treatment of epididymal obstruction; however, the success rate and anastomotic patency rate are not high, which cannot meet the modern human demand for a cure rate for this disease. Based on our preliminary research, we have reason to speculate that the new 2-suture circular intussusception vasoepididymostomy (CIVE) surgery group can greatly improve the anastomosis rate and success rate of treating epididymal obstruction patients. LIVE has become the preferred technique for epididymal and vas deferens anastomosis in North America, Europe, and globally for 22 years. Compared with LIVE, CIVE can greatly improve the anastomosis and success rate of treating epididymal obstruction patients. The aim of this study is to make CIVE the preferred technique for treating epididymal obstruction in North America, Europe, and globally. CIVE ultimately benefits more patients.
Thirty-three male rats (type: Sprague-Dawley, SD) were randomly divided into control (group I) and experimental groups (groups II and III). After 3 weeks of epididymal obstruction, bilateral vasoepididymostomy was performed. In group II, the epididymal tubules (the epididymal tubules, which were cut into circular incisions) were punctured and lifted with a suture under a microscope, the vas deferens was incised obliquely at 45° for CIVE. In group III: LIVE was performed. After 3 months, patency was assessed in a blinded manner.
The rates of functional patency (presence of motile sperm in the vas deferens) were 90.9% and 63.6% in groups II and III, respectively (single-tailed test, P=0.042). On retrograde methylene blue vasography of the epididymis, the mechanical patency rate was similar to the functional patency rate. The incidence of sperm granulomas in postoperative groups II and III was 0% and 18.2%, respectively, with a single-tailed test P value of 0.24. Due to insufficient sample size, the sample size can be expanded for further verification in the later stage.
Compared with LIVE, CIVE at a 45° oblique incision of the vas deferens provides a larger anastomotic area and has a higher recanalization rate, which is worthy of further investigation. The aim of this study is to propose a new surgical approach called 'CIVE'. By expanding the anastomotic area to reduce the risk of traditional surgical failure, the ultimate goal is to provide patients with safer and more efficient treatment options.
两针纵向套叠式输精管附睾吻合术(LIVE)治疗附睾梗阻已得到多项研究证实;然而,其成功率和吻合通畅率不高,无法满足现代人们对该病治愈率的需求。基于我们的初步研究,我们有理由推测新的两针环形套叠式输精管附睾吻合术(CIVE)手术组能够大幅提高治疗附睾梗阻患者的吻合率和成功率。22年来,LIVE已成为北美、欧洲及全球范围内附睾与输精管吻合的首选技术。与LIVE相比,CIVE能大幅提高治疗附睾梗阻患者的吻合率和成功率。本研究的目的是使CIVE成为北美、欧洲及全球治疗附睾梗阻的首选技术。CIVE最终将使更多患者受益。
33只雄性大鼠(品种:Sprague-Dawley,SD)随机分为对照组(I组)和实验组(II组和III组)。附睾梗阻3周后,进行双侧输精管附睾吻合术。II组在显微镜下用缝线穿刺并提起附睾管(切成环形切口的附睾管),输精管以45°斜行切开进行CIVE。III组:进行LIVE。3个月后,以盲法评估通畅情况。
II组和III组的功能通畅率(输精管中有活动精子)分别为90.9%和63.6%(单尾检验,P = 0.042)。在附睾逆行亚甲蓝血管造影中,机械通畅率与功能通畅率相似。术后II组和III组精子肉芽肿的发生率分别为0%和18.2%,单尾检验P值为0.24。由于样本量不足,后期可扩大样本量进行进一步验证。
与LIVE相比,输精管45°斜行切开的CIVE提供了更大的吻合面积,再通率更高,值得进一步研究。本研究的目的是提出一种名为“CIVE”的新手术方法。通过扩大吻合面积以降低传统手术失败的风险,最终目标是为患者提供更安全、更有效的治疗选择。